Healio Interviews Dr. Mario Naranjo-Tovar About Risk Assessment Tool for Patients With Chronic Lung Disease, Pulmonary Hypertension and Risk for 1-Year Mortality

Healio interviewed Mario Naranjo-Tovar, MD, MHS, Assistant Professor of Clinical Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, about findings published in BMC Pulmonary Medicine which found a risk assessment tool that included five factors identified whether patients with chronic lung disease and pulmonary hypertension face a high, intermediate or low risk for 1-year mortality.